Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients Francine ChenouBidossessi Wilfried HounkpeMagnun Nueldo Nunes dos Santos Original Article 28 August 2021 Pages: 2669 - 2676
Platelet features allow to differentiate immune thrombocytopenia from inherited thrombocytopenia Guillaume BonnardAntoine BabutyMarc Fouassier Original Article 14 September 2021 Pages: 2677 - 2682
Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in northern Italy in the last 15 years Lorena DucaIsabella NavaGiovanna Graziadei Original Article 17 September 2021 Pages: 2683 - 2688
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab Alexander D. KulaginVadim V. PtushkinDmitry A. Kudlay Original Article Open access 16 August 2021 Pages: 2689 - 2698
Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis Erpeng YangMingjing WangXiaomei Hu Original Article Open access 12 August 2021 Pages: 2699 - 2706
Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies Rohit SekhriParvis SadjadianKai Wille Original Article Open access 31 August 2021 Pages: 2707 - 2716
Long-term trends in the clinical outcomes of patients with acute myeloid leukemia: a population-based real-world data analysis using the Osaka Cancer Registry Shigeo FujiShuhei KidaJun Ishikawa Original Article 03 September 2021 Pages: 2717 - 2725
Loss of CD22 expression and expansion of a CD22dim subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin Jochim ReinertAntonia Beitzen-HeinekeStefan Schwartz Original Article Open access 31 July 2021 Pages: 2727 - 2732
The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis Ramona WullenkordPhilipp BerningMatthias Stelljes Original Article Open access 03 September 2021 Pages: 2733 - 2744
Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma Tomonori NakazatoMasao HagiharaMasaaki Higashihara Original Article 31 July 2021 Pages: 2745 - 2754
Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome Xue-min GaoYan-ying YuJian Li Original Article 31 July 2021 Pages: 2755 - 2761
Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis Takayoshi TachibanaJunya KandaKanto Study Group for Cell Therapy (KSGCT) Original Article 06 August 2021 Pages: 2763 - 2771
Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes Yiyang DingYuhua RuDepei Wu Original Article Open access 04 September 2021 Pages: 2773 - 2785
Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study Viviane GournayGuillaume DumasNaïke Bigé Original Article 03 September 2021 Pages: 2787 - 2797
Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue Robin ArcaniJulien ColleGilles Kaplanski Original Article 13 September 2021 Pages: 2799 - 2803
Impact of rituximab on COVID-19 outcomes Hannah LevaviGuido LancmanJanice Gabrilove Original Article 22 September 2021 Pages: 2805 - 2812
Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa Romain GueryFelipe SuarezAmbroise Marçais Original Article 13 August 2021 Pages: 2813 - 2824
Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia Tae-Hwan KimYong Won ChoiHyun Young Lee Original Article 30 September 2021 Pages: 2825 - 2830
How can fertility counseling be implemented for every newly diagnosed pediatric patient facing gonadotoxic treatment?-A single-center experience Anke BarnbrockEmilia Salzmann-ManriqueAndrea Jarisch Original Article Open access 18 September 2021 Pages: 2831 - 2841
Role of bone marrow aspiration clots for evaluating cellularity: comparison of clots, biopsies, and smears Ken TanakaHiroki HosoiTakashi Sonoki Letter to the Editor 14 July 2021 Pages: 2843 - 2844
miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms Marie-Christina MayerJohannes Lorenz BergArmin Zebisch Letter to the Editor 22 July 2021 Pages: 2845 - 2847
Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder Hiroaki NagataKodai KuriyamaJunya Kuroda Letter to the Editor 22 August 2021 Pages: 2849 - 2850
Life-threatening paraneoplastic cardiovascular events in ALK-positive anaplastic large cell lymphoma Charlotte VerhaegheBjörn MeijersF. J. Sherida H. Woei-A-Jin Letter to the Editor 29 September 2021 Pages: 2851 - 2853
Thrombotic thrombocytopenic purpura as the presenting feature of human herpesvirus 6 myocarditis Yu-Yan HwangRock Y. Y. LeungYok-Lam Kwong Letter to the Editor 26 March 2021 Pages: 2855 - 2856
Education of early palliative care specialists among hematologists and oncologists to address patients’ rather than physicians’ rights Leonardo PotenzaMario LuppiElena Bandieri Letter to the Editor 10 April 2021 Pages: 2857 - 2858
A Filipino infant with severe neutropenia owing to SRP54 mutations was successfully treated with ethnically mismatched cord blood transplantation from a Japanese cord blood bank Takeaki TamuraHiroshi YagasakiIchiro Morioka Letter to the Editor 10 April 2021 Pages: 2859 - 2860
Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib Ivan KrečakMarina ČengićVelka Gverić-Krečak Letter to the Editor 10 June 2021 Pages: 2861 - 2862
JAK2V617F mutation in patients with β-thalassemia disease: prevalence and clinical characteristics Nattiya TeawtrakulSiriyakorn ChansaiPiti Ungarreevittaya Letter to the Editor 28 June 2021 Pages: 2863 - 2865
Hematological effects on peri-transplant use of linezolid in adults undergoing single-unit cord blood transplantation Takeo YasuTakaaki KonumaArinobu Tojo Letter to the Editor 17 July 2021 Pages: 2867 - 2869
An abdominal mass with thrombosis due to inferior vena cava agenesis mimicking lymphoma Maaike WeijmansRosa VermeulenHenk-Jan Boiten Letter to the Editor 02 August 2021 Pages: 2871 - 2872
Composite diffuse large B-cell and peripheral T-cell lymphoma with T-helper phenotype treated with both rituximab and brentuximab vedotin Kouichi OhyaShuhei OkuyamaKatsushi Tajima Letter to the Editor 24 August 2021 Pages: 2873 - 2875
Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials Thomas HeinickeRainer KrahlDietger Niederwieser Correction 16 September 2021 Pages: 2877 - 2878